These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30396062)

  • 1. NMR fragment-based screening for development of the CD44-binding small molecules.
    Pustuła M; Czub M; Łabuzek B; Surmiak E; Tomala M; Twarda-Clapa A; Guzik K; Popowicz GM; Holak TA
    Bioorg Chem; 2019 Feb; 82():284-289. PubMed ID: 30396062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-induced structural changes of the CD44 hyaluronan-binding domain revealed by NMR.
    Takeda M; Ogino S; Umemoto R; Sakakura M; Kajiwara M; Sugahara KN; Hayasaka H; Miyasaka M; Terasawa H; Shimada I
    J Biol Chem; 2006 Dec; 281(52):40089-95. PubMed ID: 17085435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomistic fingerprint of hyaluronan-CD44 binding.
    Vuorio J; Vattulainen I; Martinez-Seara H
    PLoS Comput Biol; 2017 Jul; 13(7):e1005663. PubMed ID: 28715483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand binding to anti-cancer target CD44 investigated by molecular simulations.
    Nguyen TT; Tran DP; Pham Dinh Quoc Huy ; Hoang Z; Carloni P; Van Pham P; Nguyen C; Li MS
    J Mol Model; 2016 Jul; 22(7):165. PubMed ID: 27342250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction.
    Banerji S; Wright AJ; Noble M; Mahoney DJ; Campbell ID; Day AJ; Jackson DG
    Nat Struct Mol Biol; 2007 Mar; 14(3):234-9. PubMed ID: 17293874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44.
    Teriete P; Banerji S; Noble M; Blundell CD; Wright AJ; Pickford AR; Lowe E; Mahoney DJ; Tammi MI; Kahmann JD; Campbell ID; Day AJ; Jackson DG
    Mol Cell; 2004 Feb; 13(4):483-96. PubMed ID: 14992719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
    Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS
    Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44.
    Somasunderam A; Thiviyanathan V; Tanaka T; Li X; Neerathilingam M; Lokesh GL; Mann A; Peng Y; Ferrari M; Klostergaard J; Gorenstein DG
    Biochemistry; 2010 Oct; 49(42):9106-12. PubMed ID: 20843027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms regulating the binding activity of CD44 to hyaluronic acid.
    Liu D; Liu T; Li R; Sy MS
    Front Biosci; 1998 Jul; 3():d631-6. PubMed ID: 9634638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid/polyethylene glycol nanoparticles for controlled delivery of mitoxantrone.
    Sargazi A; Kamali N; Shiri F; Heidari Majd M
    Artif Cells Nanomed Biotechnol; 2018 May; 46(3):500-509. PubMed ID: 28503952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 and hyaluronan binding by human myeloid cells.
    Smadja-Joffe F; Legras S; Girard N; Li Y; Delpech B; Bloget F; Morimoto K; Le Bousse-Kerdiles C; Clay D; Jasmin C; Levesque JP
    Leuk Lymphoma; 1996 May; 21(5-6):407-20, color plates following 528. PubMed ID: 9172805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan recognition mode of CD44 revealed by cross-saturation and chemical shift perturbation experiments.
    Takeda M; Terasawa H; Sakakura M; Yamaguchi Y; Kajiwara M; Kawashima H; Miyasaka M; Shimada I
    J Biol Chem; 2003 Oct; 278(44):43550-5. PubMed ID: 12928429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of hyaluronic acid oligosaccharides with a GlcNAc-GlcA repeating pattern and their binding affinity with CD44.
    Yeh CJ; Zulueta MML; Li YK; Hung SC
    Org Biomol Chem; 2020 Jul; 18(28):5370-5387. PubMed ID: 32638804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan.
    Wolny PM; Banerji S; Gounou C; Brisson AR; Day AJ; Jackson DG; Richter RP
    J Biol Chem; 2010 Sep; 285(39):30170-80. PubMed ID: 20663884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of peptide mimics of hyaluronic acid with the receptor for hyaluronan mediated motility (RHAMM).
    Ziebell MR; Prestwich GD
    J Comput Aided Mol Des; 2004 Oct; 18(10):597-614. PubMed ID: 15849992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cell Surface Receptor CD44: NMR-Based Characterization of Putative Ligands.
    Baggio C; Barile E; Di Sorbo G; Kipps TJ; Pellecchia M
    ChemMedChem; 2016 May; 11(10):1097-106. PubMed ID: 27144715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment-based identification of an inducible binding site on cell surface receptor CD44 for the design of protein-carbohydrate interaction inhibitors.
    Liu LK; Finzel BC
    J Med Chem; 2014 Mar; 57(6):2714-25. PubMed ID: 24606063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
    Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
    Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid.
    Liu D; Sy MS
    J Exp Med; 1996 May; 183(5):1987-94. PubMed ID: 8642309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular weight specific impact of soluble and immobilized hyaluronan on CD44 expressing melanoma cells in 3D collagen matrices.
    Sapudom J; Ullm F; Martin S; Kalbitzer L; Naab J; Möller S; Schnabelrauch M; Anderegg U; Schmidt S; Pompe T
    Acta Biomater; 2017 Mar; 50():259-270. PubMed ID: 27965172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.